Targeting the Labile Iron Pool with Engineered DFO Nanosheets to Inhibit Ferroptosis for Parkinson's Disease Therapy
Advanced Materials · 2024-10 · 36 (41)
DOI: 10.1002/adma.202409329 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 02.09.2024. Verfasst von Li Lei und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Engineering Research Center for Molecular Medicine, College of Basic Medical Science, Guizhou Medical University, Guiyang, 5…. Hauptthemen laut MEDLINE: Ferroptosis, Parkinson Disease, Iron, Deferoxamine. Die Arbeit wurde bisher 84-mal zitiert (Crossref) und nennt 79 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guizhou Provincial Science and Technology Projects, Elexible Talents Program of Guizhou Medical University.
Abstract (Originalsprache)
Ferroptosis in neurons is considered one of the key factors that induces Parkinson's disease (PD), which is caused by excessive iron accumulation in the intracellular labile iron pool (LIP). The iron ions released from the LIP lead to the aberrant generation of reactive oxygen species (ROS) to trigger ferroptosis and exacerbate PD progression. Herein, a pioneering design of multifunctional nanoregulator deferoxamine (DFO)‐integrated nanosheets (BDPR NSs) is presented that target the LIP to restrict ferroptosis and protect against PD. The BDPR NSs are constructed by incorporating a brain‐targeting peptide and DFO into polydopamine‐modified black phosphorus nanosheets. These BDPR NSs can sequester free iron ions, thereby ameliorating LIP overload and regulating iron metabolism. Furthermore, the BDPR NSs can decrease lipid peroxidation generation by mitigating ROS accumulation. More importantly, BDPR NSs can specifically accumulate in the mitochondria to suppress ROS generation and decrease mitochondrial iron accumulation. In vivo experiments demonstrated that the BDPR NSs highly efficiently mitigated dopaminergic neuronloss and its associated behavioral disorders by modulating the LIP and inhibiting ferroptosis. Thus, the BDPR‐based nanovectors holds promise as a potential avenue for advancing PD therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Engineering Research Center for Molecular Medicine, College of Basic Medical Science, Guizhou Medical University, Guiyang, 550025, China.
- Department of Neurosurgery, the Affiliated Hospital of Guizhou Medical University, Guiyang, 550025, China.
- Department of Biology, Engineering Research Center for Molecular Medicine, College of Basic Medical Science, Guizhou Medical University, Guiyang, 550025, China.
- Guizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, College of Pharmacy, Guizhou Medical University, Guiyang, 550025, China.
- The Jinyang Hospital Affiliated to Guizhou Medical University: The Second People's Hospital of Guiyang, Guiyang, 550025, China.
- Key Laboratory of Endemic and Ethnic Diseases, Ministry of Education & Key Laboratory of Medical Molecular Biology of Guizhou Province, Guizhou Medical University, Guiyang, 550004, China.
ORCID-Profile: Li Lei
Förderung
- National Natural Science Foundation of China
- Guizhou Provincial Science and Technology Projects
- Elexible Talents Program of Guizhou Medical University
- Young scientific and technological talents of Guizhou Provincial Department of Education
- Science and technology research project of traditional Chinese medicine and ethnic medicine of Guizhou Province Administration of Traditional Chinese Medicine
- Cultivation program of Guizhou Medical University
- National College Students Innovation and Entrepreneurship Training Program
Zitieren
APA
Lei, L., Yuan, J., Dai, Z., Xiang, S., Tu, Q., Cui, X., Zhai, S., Chen, X., He, Z., Fang, B., Xu, Z., Yu, H., Tang, L., & Zhang, C. (2024). Targeting the Labile Iron Pool with Engineered DFO Nanosheets to Inhibit Ferroptosis for Parkinson's Disease Therapy. Advanced Materials, 36(41). https://doi.org/10.1002/adma.202409329
Vancouver
Lei L, Yuan J, Dai Z, Xiang S, Tu Q, Cui X, et al. Targeting the Labile Iron Pool with Engineered DFO Nanosheets to Inhibit Ferroptosis for Parkinson's Disease Therapy. Advanced Materials. 2024;36(41). doi:10.1002/adma.202409329
BibTeX
@article{Lei2024,
author = {Lei, Li and Yuan, Jiali and Dai, Zhijun and Xiang, Song and Tu, Qiuxia and Cui, Xing and Zhai, Suzhen and Chen, Xiaozhong and He, Zhixu and Fang, Boyan and Xu, Zhiai and Yu, Haijun and Tang, Lei and Zhang, Chunlin},
title = {Targeting the Labile Iron Pool with Engineered DFO Nanosheets to Inhibit Ferroptosis for Parkinson's Disease Therapy},
journal = {Advanced Materials},
year = {2024},
volume = {36},
number = {41},
doi = {10.1002/adma.202409329}
}
EUVIMED